Follow
Alak Manna
Alak Manna
Research Associate, Cancer Biology, Mayo Clinic
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Novel fluorinated curcuminoids and their pyrazole and isoxazole derivatives: Synthesis, structural studies, Computational/Docking and in-vitro bioassay
KK Laali, WJ Greves, SJ Correa-Smits, AT Zwarycz, SD Bunge, ...
Journal of Fluorine Chemistry 206, 82-98, 2018
712018
Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages
P Saha, S Bhattacharjee, A Sarkar, A Manna, S Majumder, M Chatterjee
PLoS One 6 (4), e18467, 2011
692011
Andrographolide analogue induces apoptosis and autophagy mediated cell death in U937 cells by inhibition of PI3K/Akt/mTOR pathway
D Kumar, B Das, R Sen, P Kundu, A Manna, A Sarkar, C Chowdhury, ...
PLoS One 10 (10), e0139657, 2015
602015
Malabaricone-A induces a redox imbalance that mediates apoptosis in U937 cell line
A Manna, P Saha, A Sarkar, D Mukhopadhyay, AK Bauri, D Kumar, P Das, ...
PLoS One 7 (5), e36938, 2012
592012
Waldenstrom macroglobulinemia cells devoid of BTKBTKC481S or CXCR4CXCR4WHIM-like mutations acquire resistance to ibrutinib through upregulation of …
A Paulus, S Akhtar, H Yousaf, A Manna, SM Paulus, Y Bashir, ...
Blood cancer journal 7 (5), e565, 2017
532017
Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naive CD4+ T cells
S Chatterjee, S Das, P Chakraborty, A Manna, M Chatterjee, ...
Immunobiology 218 (5), 718-724, 2013
512013
Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis
D Mukhopadhyay, NK Das, S De Sarkar, A Manna, DN Ganguly, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 106 (11 …, 2012
342012
Allylpyrocatechol attenuates collagen-induced arthritis via attenuation of oxidative stress secondary to modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 pathways
S De, A Manna, S Kundu, S De Sarkar, U Chatterjee, T Sen, ...
Journal of Pharmacology and Experimental Therapeutics 360 (2), 249-259, 2017
322017
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic LeukemiaDaratumumab and Ibrutinib in CLL
A Manna, S Aulakh, P Jani, S Ahmed, S Akhtar, M Coignet, M Heckman, ...
Clinical Cancer Research 25 (13), 3974-3985, 2019
302019
The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance
A Manna, S De Sarkar, S De, AK Bauri, S Chattopadhyay, M Chatterjee
Phytomedicine 22 (7-8), 713-723, 2015
302015
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
A Manna, T Kellett, S Aulakh, LJ Lewis-Tuffin, N Dutta, K Knutson, E Chini, ...
Blood Advances 4 (10), 2143-2157, 2020
282020
The antioxidant activity of allylpyrocatechol is mediated via decreased generation of free radicals along with escalation of antioxidant mechanisms
D Sarkar, S Kundu, S De, C Hariharan, P Saha, A Manna, ...
Phytotherapy research 27 (3), 324-329, 2013
252013
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells
A Paulus, A Manna, S Akhtar, SM Paulus, M Sharma, MV Coignet, L Jiang, ...
British journal of haematology 183 (2), 196-211, 2018
222018
Lisaftoclax (APG-2575) is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Clinical cancer Research, 2022
162022
Survival trends in glioblastoma and association with treating facility volume
S Aulakh, MR DeDeo, J Free, SS Rosenfeld, A Quinones-Hinojosa, ...
Journal of Clinical Neuroscience, 2019
152019
Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity
KK Laali, WJ Greves, AT Zwarycz, SJ Correa Smits, FJ Troendle, ...
ChemMedChem 13 (18), 1895-1908, 2018
142018
Oncogenic potential of hepatitis B virus subgenotype D1 surpasses D3: significance in the development of hepatocellular carcinoma
S Datta, D Dasgupta, A Ghosh, S Ghosh, A Manna, S Datta, M Chatterjee, ...
Carcinogenesis 39 (2), 283-292, 2017
142017
Impact of MAPK and PI3K/AKT signaling pathways on Malabaricone-A induced cytotoxicity in U937, a histiocytic lymphoma cell line
A Manna, S De Sarkar, S De, AK Bauri, S Chattopadhyay, M Chatterjee
International immunopharmacology 39, 34-40, 2016
102016
CD38-targeted therapy in glioblastoma: A step forward.
S Aulakh, A Manna, P Schiapparelli, S Ailawadhi, A Paulus, S Rosenfeld, ...
Journal of Clinical Oncology 36 (15_suppl), e14030-e14030, 2018
9*2018
Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies
Y Luo, Y Qie, ME Gadd, A Manna, R Rivera-Valentin, T To, S Li, F Yassine, ...
Cancer Immunology, Immunotherapy, 1-17, 2023
62023
The system can't perform the operation now. Try again later.
Articles 1–20